Goldman Sachs’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $208K | Sell |
|
|||||
|
2024
Q4 | $493K | Buy |
|
|||||
|
2024
Q3 | $183K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $23M | Sell |
|
|||||
|
2023
Q4 | $1.03M | Buy |
|
|||||
|
2023
Q3 | $1.42M | Sell |
|
|||||
|
2023
Q2 | $1.58M | Buy |
|
|||||
|
2023
Q1 | $536K | Buy |
|
|||||
|
2022
Q4 | $88.3K | Sell |
|
|||||
|
2022
Q3 | $246K | Sell |
|
|||||
|
2022
Q2 | $344K | Sell |
|
|||||
|
2022
Q1 | $1.43M | Sell |
|
|||||
|
2021
Q4 | $4M | Sell |
|
|||||
|
2021
Q3 | $5.39M | Sell |
|
|||||
|
2021
Q2 | $6.75M | Sell |
|
|||||
|
2021
Q1 | $9.62M | Buy |
|
|||||
|
2020
Q4 | $1.79M | Buy |
|
|||||
|
2020
Q3 | $487K | Buy |
|
|||||
|
2020
Q2 | $160K | Sell |
|
|||||
|
2020
Q1 | $230K | Buy |
|
|||||
|
2019
Q4 | $42K | Sell |
|
|||||
|
2019
Q3 | $43K | Buy |
|
|||||
|
2019
Q2 | $38K | Sell |
|
|||||
|
2019
Q1 | $52K | Sell |
|
|||||
|
2018
Q4 | $81K | Buy |
|
|||||
|
2018
Q3 | $380K | Buy |
|
|||||
|
2018
Q2 | $244K | Buy |
|
|||||
|
2018
Q1 | $113K | Sell |
|
|||||
|
2017
Q4 | $289K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $452K | Buy |
|
|||||
|
2016
Q4 | $296K | Sell |
|
|||||
|
2016
Q3 | $773K | Buy |
|
|||||
|
2016
Q2 | $350K | Buy |
|